FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136178192> ?p ?o ?g. }

• W3136178192 endingPage "101542" @default.
• W3136178192 startingPage "101542" @default.
• W3136178192 abstract "Present treatment strategy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma (PDAC) patients is controversial. Hence, a triple-modal therapy, which is a multidisciplinary strategy, was designed for patients with UR-LA PDAC by adding hyperthermia to conventional chemoradiotherapy at our institution. In this study we aimed to evaluate the effectiveness of this strategy.Data of 21 UR-LA PDAC patients who underwent the triple-modal treatment were retrospectively analyzed for evaluating the safety and oncological effect of the treatment. The treatment schedule included, five concurrent infusions of gemcitabine (800 mg/m2) followed by hyperthermia (1 h) and X-ray (2 Gy) or proton beam radiation (2.7 Gy) on days 1, 8, 15, 29, and 36. Additional radiotherapies applied a total dose of 50 Gy/25 fr for X-ray radiation or 67.5 Gy/25 fr for proton beam radiation.Median overall survival (OS) was 23.6 months. Conversion surgery was performed in 5 patients (23.8%), and a R0 margin could be achieved in 4 of them; however, their median OS (16.3 months) tended to be shorter than that of the patients who did not undergo resection (23.6 months, p = 0.562). Further, the median OS of patients who underwent proton beam radiation (28.0 months) was significantly longer than that of patients who underwent X-ray radiation (13.9 months, p = 0.045). Most adverse events were manageable, except for one grade 3 gastric ulcer. The median tumor size and marker reduction rates were -17% and -91%, respectively. The tumor responses were partial response, stable disease, and progressive disease in 3, 15, and 3 patients, respectively.Triple-modal strategy, especially when combined with proton beam radiation, is feasible and results in favorable survival outcomes in patients with UR-LA PDAC." @default.
• W3136178192 created "2021-03-29" @default.
• W3136178192 creator A5000435566 @default.
• W3136178192 creator A5005882584 @default.
• W3136178192 creator A5020044987 @default.
• W3136178192 creator A5036960171 @default.
• W3136178192 creator A5040877327 @default.
• W3136178192 creator A5043452264 @default.
• W3136178192 creator A5044046229 @default.
• W3136178192 creator A5045506047 @default.
• W3136178192 creator A5046290767 @default.
• W3136178192 creator A5067463277 @default.
• W3136178192 creator A5085164052 @default.
• W3136178192 creator A5085477743 @default.
• W3136178192 creator A5085995740 @default.
• W3136178192 creator A5086909167 @default.
• W3136178192 creator A5090962497 @default.
• W3136178192 creator A5091639568 @default.
• W3136178192 date "2021-06-01" @default.
• W3136178192 modified "2023-10-18" @default.
• W3136178192 title "Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma" @default.
• W3136178192 cites W1911698430 @default.
• W3136178192 cites W1964246836 @default.
• W3136178192 cites W1985367511 @default.
• W3136178192 cites W1991264254 @default.
• W3136178192 cites W1998805086 @default.
• W3136178192 cites W2055091294 @default.
• W3136178192 cites W2061174719 @default.
• W3136178192 cites W2064437057 @default.
• W3136178192 cites W2082398974 @default.
• W3136178192 cites W2103711657 @default.
• W3136178192 cites W2127233803 @default.
• W3136178192 cites W2130746306 @default.
• W3136178192 cites W2135064511 @default.
• W3136178192 cites W2143953275 @default.
• W3136178192 cites W2154935750 @default.
• W3136178192 cites W2303515996 @default.
• W3136178192 cites W2313528623 @default.
• W3136178192 cites W2345822778 @default.
• W3136178192 cites W2347166343 @default.
• W3136178192 cites W2413386818 @default.
• W3136178192 cites W2588123889 @default.
• W3136178192 cites W2598133780 @default.
• W3136178192 cites W2607424804 @default.
• W3136178192 cites W2611304063 @default.
• W3136178192 cites W2741861824 @default.
• W3136178192 cites W2743061229 @default.
• W3136178192 cites W2768972958 @default.
• W3136178192 cites W2801301689 @default.
• W3136178192 cites W2911996304 @default.
• W3136178192 cites W2934096806 @default.
• W3136178192 doi "https://doi.org/10.1016/j.suronc.2021.101542" @default.
• W3136178192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33740629" @default.
• W3136178192 hasPublicationYear "2021" @default.
• W3136178192 type Work @default.
• W3136178192 sameAs 3136178192 @default.
• W3136178192 citedByCount "6" @default.
• W3136178192 countsByYear W31361781922021 @default.
• W3136178192 countsByYear W31361781922022 @default.
• W3136178192 countsByYear W31361781922023 @default.
• W3136178192 crossrefType "journal-article" @default.
• W3136178192 hasAuthorship W3136178192A5000435566 @default.
• W3136178192 hasAuthorship W3136178192A5005882584 @default.
• W3136178192 hasAuthorship W3136178192A5020044987 @default.
• W3136178192 hasAuthorship W3136178192A5036960171 @default.
• W3136178192 hasAuthorship W3136178192A5040877327 @default.
• W3136178192 hasAuthorship W3136178192A5043452264 @default.
• W3136178192 hasAuthorship W3136178192A5044046229 @default.
• W3136178192 hasAuthorship W3136178192A5045506047 @default.
• W3136178192 hasAuthorship W3136178192A5046290767 @default.
• W3136178192 hasAuthorship W3136178192A5067463277 @default.
• W3136178192 hasAuthorship W3136178192A5085164052 @default.
• W3136178192 hasAuthorship W3136178192A5085477743 @default.
• W3136178192 hasAuthorship W3136178192A5085995740 @default.
• W3136178192 hasAuthorship W3136178192A5086909167 @default.
• W3136178192 hasAuthorship W3136178192A5090962497 @default.
• W3136178192 hasAuthorship W3136178192A5091639568 @default.
• W3136178192 hasBestOaLocation W31361781921 @default.
• W3136178192 hasConcept C126322002 @default.
• W3136178192 hasConcept C126838900 @default.
• W3136178192 hasConcept C2775908122 @default.
• W3136178192 hasConcept C2776694085 @default.
• W3136178192 hasConcept C2777416452 @default.
• W3136178192 hasConcept C2778424827 @default.
• W3136178192 hasConcept C2779949491 @default.
• W3136178192 hasConcept C2780258809 @default.
• W3136178192 hasConcept C2989005 @default.
• W3136178192 hasConcept C509974204 @default.
• W3136178192 hasConcept C71924100 @default.
• W3136178192 hasConceptScore W3136178192C126322002 @default.
• W3136178192 hasConceptScore W3136178192C126838900 @default.
• W3136178192 hasConceptScore W3136178192C2775908122 @default.
• W3136178192 hasConceptScore W3136178192C2776694085 @default.
• W3136178192 hasConceptScore W3136178192C2777416452 @default.
• W3136178192 hasConceptScore W3136178192C2778424827 @default.
• W3136178192 hasConceptScore W3136178192C2779949491 @default.
• W3136178192 hasConceptScore W3136178192C2780258809 @default.
• W3136178192 hasConceptScore W3136178192C2989005 @default.

• next